8 March 2016, 9am-5.15pm, Amphith\u00e9\u00e2tre E3\/3 (Campus moulins, 1 Place D\u00e9liot, Lille). Conference under the scientific direction of B\u00e9reng\u00e8re LEGROS, HDR lecturer at the University of Lille.<\/p>\n
Nanotechnologies are emerging technologies that have led to the creation of nano-objects in the context of international competition. Some of these are for medical use, providing diagnostic, therapeutic or monitoring tools for the human body. These objects must be traceable. But this is not the case for nano-objects that are not for medical use and to which the workers who manufacture and\/or use them, as well as the consumers who buy products in which they are incorporated, are exposed. However, when it comes to these nano-objects, current knowledge of the possible risks and dangers to health and the environment is inadequate. Health risks are difficult to assess because there is no standardised method for making such an assessment, as each nano-object has a different and unique formulation or matrix.<\/p>\n
These ubiquitous technological advances are a source of fascination and hope, but also of concern. But how does the law react to this daily, partly invisible invasion? What about the regulation chosen in the light of all the branches of domestic law that are being or are likely to be called upon: environmental law, the genesis of nanotechnology law, bioethics law, medical law, social law, pharmaceutical law, industrial property law, because of the economic stakes involved, but also liability law? What about the role of European standards and how they relate to national standards?<\/p>\n
The spread of nano-objects also raises questions of a social and ethical nature, particularly concerning the appropriateness and purpose of some of their applications and the risk of possible aberrations. This could be the case with therapies for repairing motor functions, which could amplify the performance of healthy subjects and create the risk of the emergence of a new humanity, a society tending towards transhumanism. This could also be the case for new forms of body surveillance, which would make possible an \"intelligent environment\" thanks to technologies that enable the collection and analysis of data on the health of individuals.<\/p>\n
Are the current legal regulations satisfactory, or shouldn't precautionary principles and measures be applied more widely? What are we to think, too, of the Council of Europe's renewal of standards in the face of technological convergence, in particular the \"NBIC convergence\" - i.e. the interactions between nanotechnologies, biology, information technologies and cognitive sciences - to ensure the safety of citizens, businesses and the environment?<\/p>\n
The aim of this conference will be to encourage reflection on the possible prospects for changes in standards, both in domestic law and in European law, by including a non-legal (medical and ethical) perspective.<\/b><\/p>\nPROGRAMME<\/h2>\n
8h45 | <\/b>Accueil des participants<\/b><\/p>\n
<\/p>\n
9h00 |<\/b> Opening speeches<\/b><\/p>\n B\u00e9reng\u00e8re LEGROS, Senior Lecturer at the Faculty of Legal, Political and Social Sciences, University of Lille (CRD&P- L'ERDS)<\/p>\n Morning session chaired by Professor R\u00e9gis BEUSCART, <\/p>\n 11.10 a.m. | Break<\/p>\n <\/p>\n <\/p>\n 12.30 pm | Lunch break<\/p>\n <\/p>\n Afternoon, chaired by Sonia DESMOULIN, <\/p>\n 15h15 | Pause<\/p>\n <\/p>\n <\/p>\n 17h15 | Cl\u00f4ture du colloque<\/p>","protected":false},"excerpt":{"rendered":" Les nanotechnologies et nano-objets \u00e0 l’\u00e9preuve des droits, de la sant\u00e9 et de l’\u00e9thique 8 Mars 2016, Campus Moulin, Lille.<\/p>","protected":false},"author":2,"featured_media":8898,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-8897","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"_links":{"self":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts\/8897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/comments?post=8897"}],"version-history":[{"count":0,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts\/8897\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/media\/8898"}],"wp:attachment":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/media?parent=8897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/categories?post=8897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/tags?post=8897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
9h20 | Introductory remarks<\/h3>\n
\nDirector of the Centre d'Etudes et de Recherche en Informatique M\u00e9dicale at the Faculty of Medicine, University of Lille<\/p>\n<\/h3>\n
I - Medical and pharmaceutical aspects<\/h3>\n
\n
\n
<\/h3>\n
II - Health and environmental aspects<\/h3>\n
\n
\n
\n
\n
\nCNRS Research Fellow, Law and Social Change Laboratory, CNRS\/University of Nantes<\/p>\nIII - Social and property aspects<\/h3>\n
\n
\n
IV \u2013 Aspects \u00e9thiques et bio\u00e9thiques<\/h3>\n
\n